Developing innovative drugs through the commons Lessons from the DNDi experience

Autor: Coriat, Benjamin, Abécassis, P., Alessandrini, J-F, Coutinet, Nathalie, LEYRONAS, Stéphanie
Přispěvatelé: Centre d'Economie de l'Université Paris Nord (CEPN), LABEX ICCA, Université Paris 13 (UP13)-Université Sorbonne Nouvelle - Paris 3-Centre National de la Recherche Scientifique (CNRS)-Université de Paris (UP)-Université Sorbonne Paris Nord-Université Paris 13 (UP13)-Université Sorbonne Nouvelle - Paris 3-Centre National de la Recherche Scientifique (CNRS)-Université de Paris (UP)-Université Sorbonne Paris Nord-Centre National de la Recherche Scientifique (CNRS), Drugs for Neglected Diseases initiative Latin America (DNDi), Drugs for Neglected Diseases Initiative, Agence française de développement (AFD), Projet de Recherche Entreprendre en Communs (EnCommuns)
Jazyk: angličtina
Rok vydání: 2019
Předmět:
Popis: In this paper we argue that DNDi, even though it belongs to the family of Product Development Partnerships (PDPs) created at the end of the 20th century, has followed a very particular trajectory, that allows us to characterize it as a distinctive commons in the field of public health. We illustrate this view by focusing on two features: DNDi’s promotion of collaborative platforms and its innovative intellectual property policy.
Databáze: OpenAIRE